EUVIMEDEUVIMED entdecken
Crossref

Clinical and imaging differences between pancreatic carcinoma in situ and T1a/T1b pancreatic ductal adenocarcinoma

Tatsunori Satoh, Shinya Kawaguchi, Eiji Nakatani, Haruna Takahashi, Shinya Endo, Naofumi Shirane, Hideyuki Kanemoto, Kazuya Ohno

Abdominal Radiology · 16.03.2026 · 51 (9) · 4456-4464

DOI: 10.1007/s00261-026-05453-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Abdominal Radiology, online erschienen am 16.03.2026. Verfasst von Tatsunori Satoh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Shizuoka General Hospital, Shizuoka, Japan. tatsunori-sato@i.shizuoka-pho.jp. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Positron Emission Tomography Computed Tomography, Carcinoma in Situ. Die Arbeit nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/OBJECTIVES: Accurate differentiation between pancreatic carcinoma in situ (CIS) and small invasive pancreatic ductal adenocarcinoma (PDAC) is critical for optimizing patient management. This study aimed to assess the diagnostic performance of restricted diffusion on DWI and FDG uptake on PET-CT in distinguishing T1a/T1b PDAC from CIS. METHODS: We retrospectively analyzed 37 patients (23 with CIS and 14 with T1a/T1b PDAC) who underwent preoperative CT, MRI, endoscopic ultrasonography (EUS), and 18F-fluorodeoxyglucose (FDG) PET-CT. Imaging findings, including hypoechoic area around the main pancreatic duct, restricted diffusion on diffusion-weighted MRI (DWI-MRI), and FDG uptake on PET-CT, were compared between the groups. Logistic regression analyses were performed to identify predictors of T1a/T1b PDAC. RESULTS: Among the T1a/T1b PDAC group, FDG uptake was observed in 6 (42.9%), contrasting sharply with only 1 of 23 CIS patients (4.3%) (p = 0.007). Restricted diffusion on DWI was more frequent in T1a/T1b PDAC (50.0%) than in CIS (17.4%), but did not reach statistical significance (p = 0.063). FDG uptake on PET-CT demonstrated the highest specificity (95.7%) for detecting T1a/T1b PDAC, resulting in an overall diagnostic accuracy of 75.7%. DWI offered a specificity of 82.6% but only moderate sensitivity (50.0%). In multivariable analysis, FDG uptake on PET-CT emerged as the sole independent predictor of T1a/T1b PDAC (odds ratio, 13.1; 95% confidence interval, 1.29-134.0; p = 0.030). CONCLUSIONS: FDG uptake on PET-CT might be helpful in differentiating T1a/T1b PDAC from CIS. A multimodal imaging approach incorporating these findings may support more individualized treatment planning; however, further validation in larger prospective studies is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsCarcinoma, Pancreatic DuctalPositron Emission Tomography Computed TomographyCarcinoma in SituHumansFemaleMaleRetrospective StudiesAgedFluorodeoxyglucose F18Diagnosis, DifferentialRadiopharmaceuticalsMiddle AgedDiffusion Magnetic Resonance ImagingNeoplasm StagingSensitivity and SpecificityEndosonographyAged, 80 and over

Stichwörter der Autor:innen

Carcinoma in situEarly diagnosisMagnetic resonance imagingPancreatic cancerPositron emission tomography

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of Gastroenterology, Shizuoka General Hospital, Shizuoka, Japan. tatsunori-sato@i.shizuoka-pho.jp.
  • Department of Gastroenterology, Shizuoka General Hospital, Shizuoka, Japan.
  • Department of Biostatistics and Data Science, Nagoya City University, Nagoya, Japan.
  • Department of Surgery, Shizuoka General Hospital, Shizuoka, Japan.

Zitieren

APA

Satoh, T., Kawaguchi, S., Nakatani, E., Takahashi, H., Endo, S., Shirane, N., Kanemoto, H., & Ohno, K. (2026). Clinical and imaging differences between pancreatic carcinoma in situ and T1a/T1b pancreatic ductal adenocarcinoma. Abdominal Radiology, 51(9), 4456-4464. https://doi.org/10.1007/s00261-026-05453-w

Vancouver

Satoh T, Kawaguchi S, Nakatani E, Takahashi H, Endo S, Shirane N, et al. Clinical and imaging differences between pancreatic carcinoma in situ and T1a/T1b pancreatic ductal adenocarcinoma. Abdominal Radiology. 2026;51(9):4456-4464. doi:10.1007/s00261-026-05453-w

BibTeX
@article{Satoh2026,
  author = {Satoh, Tatsunori and Kawaguchi, Shinya and Nakatani, Eiji and Takahashi, Haruna and Endo, Shinya and Shirane, Naofumi and Kanemoto, Hideyuki and Ohno, Kazuya},
  title = {Clinical and imaging differences between pancreatic carcinoma in situ and T1a/T1b pancreatic ductal adenocarcinoma},
  journal = {Abdominal Radiology},
  year = {2026},
  volume = {51},
  number = {9},
  pages = {4456--4464},
  doi = {10.1007/s00261-026-05453-w}
}
Kostenlos starten →